Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

9.1K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.1K
T Cell Types and Functions01:24

T Cell Types and Functions

3.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

10.8K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

10.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.2K
Abnormal Proliferation02:23

Abnormal Proliferation

5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global and mitochondrial choline dehydrogenase contribute to goose fatty liver formation by differentially regulating energy metabolism, autophagy and oxidative stress related pathways.

Poultry science·2026
Same author

Real time prediction of instantaneous wave-free ratio based on lumped parameter and neural network models.

Computer methods and programs in biomedicine·2026
Same author

Sex differences in resting-state hypothalamic connectivity and its relationship with negative emotion and behavior measures in young adults.

Brain structure & function·2026
Same author

Non-invasive Computational Techniques for Diagnosing Myocardial Ischemia: Challenges and Future of FFR<sub>CT</sub>/iFR<sub>CT</sub>.

Annals of biomedical engineering·2026
Same author

Early-life air pollution exposure: epigenetics and child allergy.

Epigenomics·2026
Same author

The dynamic impairment of synaptic transmission in the PCx-IL engram circuit contributes to early olfactory memory decline in Alzheimer's disease.

Molecular psychiatry·2026

Related Experiment Video

Updated: Mar 16, 2026

Modified Yeast-Two-Hybrid System to Identify Proteins Interacting with the Growth Factor Progranulin
07:56

Modified Yeast-Two-Hybrid System to Identify Proteins Interacting with the Growth Factor Progranulin

Published on: January 17, 2012

29.3K

Progranulin: A key player in autoimmune diseases.

Jinlong Jian1, Guangfei Li2, Aubryanna Hettinghouse1

  • 1Department of Orthopedics Surgery, New York University School of Medicine, New York, NY 10003, United States.

Cytokine
|August 17, 2016
PubMed
Summary

Progranulin (PGRN) is an anti-inflammatory molecule that may treat autoimmune diseases by inhibiting TNFα. This review explores PGRN

Keywords:
Autoimmune diseasesProgranulinTNFTNFR

More Related Videos

Establishment of a Surgically-induced Model in Mice to Investigate the Protective Role of Progranulin in Osteoarthritis
07:58

Establishment of a Surgically-induced Model in Mice to Investigate the Protective Role of Progranulin in Osteoarthritis

Published on: February 25, 2014

29.9K
Assessing Social Dominance in Mouse Models Using the Tube Test
03:34

Assessing Social Dominance in Mouse Models Using the Tube Test

Published on: June 6, 2025

1.7K

Related Experiment Videos

Last Updated: Mar 16, 2026

Modified Yeast-Two-Hybrid System to Identify Proteins Interacting with the Growth Factor Progranulin
07:56

Modified Yeast-Two-Hybrid System to Identify Proteins Interacting with the Growth Factor Progranulin

Published on: January 17, 2012

29.3K
Establishment of a Surgically-induced Model in Mice to Investigate the Protective Role of Progranulin in Osteoarthritis
07:58

Establishment of a Surgically-induced Model in Mice to Investigate the Protective Role of Progranulin in Osteoarthritis

Published on: February 25, 2014

29.9K
Assessing Social Dominance in Mouse Models Using the Tube Test
03:34

Assessing Social Dominance in Mouse Models Using the Tube Test

Published on: June 6, 2025

1.7K

Area of Science:

  • Immunology
  • Molecular Biology
  • Rheumatology

Background:

  • Autoimmune diseases involve uncontrolled immune responses and affect multiple organs.
  • Progranulin (PGRN) is an anti-inflammatory molecule that antagonizes TNFα.
  • PGRN has shown therapeutic potential in inflammatory arthritis and other conditions.

Purpose of the Study:

  • To review recent studies on Progranulin (PGRN) as a therapeutic target for autoimmune diseases.
  • To summarize PGRN's anti-inflammatory mechanisms and its role in various autoimmune conditions.
  • To provide updated information for future research on PGRN in autoimmunity.

Main Methods:

  • Literature review of recent studies on Progranulin (PGRN) and autoimmune diseases.
  • Analysis of PGRN's anti-inflammatory pathways, including TNFα antagonism and effects on immune cells.
  • Examination of PGRN's involvement in conditions like systemic lupus erythematosus, multiple sclerosis, and Sjogren's syndrome.

Main Results:

  • PGRN acts as an endogenous antagonist of TNFα by binding to TNFR.
  • PGRN exhibits anti-inflammatory effects through Treg differentiation, IL-10 induction, and reduced chemokine release.
  • PGRN's protective roles are noted in osteoarthritis, inflammatory bowel disease, and psoriasis, but it may contribute to insulin resistance in diabetes.

Conclusions:

  • Progranulin (PGRN) is a promising therapeutic target for autoimmune diseases due to its multifaceted anti-inflammatory properties.
  • Further research is warranted to fully elucidate PGRN's role and therapeutic potential in various autoimmune conditions.
  • Understanding PGRN's complex interactions may lead to novel treatment strategies for autoimmune disorders.